Fractyl Health (GUTS) Inventory (2023 - 2024)
Fractyl Health's (GUTS) quarterly Inventory came in at $73000.0 in Q4 2024, little changed YoY from $73000.0 in Q1 2024, and little changed on a QoQ basis from $73000.0 in Q3 2024.
Fractyl Health (GUTS) Inventory (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has 2 years of Inventory data on file, last reported at $73000.0 in Q4 2024.
- Quarterly Inventory changed 0.0% year-over-year to $73000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $73000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $73000.0, changed 0.0% from the prior year.
- Inventory steadied at $73000.0 in Q4 2024, from $73000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $73000.0 in Q4 2023 to a low of $64000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 73,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |